Gene Expression Profiling × Other hematologic neoplasm × Clear all CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
Phase 2 Completed
52 enrolled
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Unknown
529 enrolled
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Active not recruiting
600 enrolled
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
Phase NA Completed
34 enrolled 12 charts
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Phase 1/2 Completed
58 enrolled 12 charts
Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
Phase 2 Completed
32 enrolled 14 charts
Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia
Completed
200 enrolled
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma
Phase 1/2 Terminated
2 enrolled 4 charts
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
Phase 1/2 Completed
25 enrolled 13 charts
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Phase 4 Completed
540 enrolled 25 charts
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Unknown
1,200 enrolled
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
Phase 1/2 Completed
29 enrolled 10 charts
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
Phase 2 Terminated
1 enrolled 5 charts
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
Phase 2 Completed
53 enrolled 10 charts
Study of Bone Marrow Samples From Patients With Acute Leukemia
Completed
40 enrolled
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy
Completed
225 enrolled
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Completed
257 enrolled
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
Phase 1/2 Completed
37 enrolled
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
Completed
20 enrolled
Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia
Completed
32 enrolled
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531
Completed
1,000 enrolled
Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial
Completed
99 enrolled
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
Completed
90 enrolled
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
Completed
75 enrolled
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
Completed
149 enrolled
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia
Completed
15 enrolled
Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia
Completed
50 enrolled
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
Completed
20 enrolled
Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia
Completed
20 enrolled
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
Completed
200 enrolled
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia
Completed
20 enrolled
Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia
Completed
6 enrolled
Studying Gene Expression in Tissue Samples From Young Patients With Acute Myeloid Leukemia
Completed
20 enrolled
S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia
Completed
290 enrolled
S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia
Completed
100 enrolled
Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Phase 2 Terminated
16 enrolled 4 charts
Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia
Phase 1 Withdrawn
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Phase 2/3 Completed
2,000 enrolled
Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment
Unknown
400 enrolled
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
Unknown
400 enrolled
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
Completed
190 enrolled
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
Unknown
200 enrolled